Ocular Surface Protection During Mechanical Ventilation: Evidence-Based Review for Clinical Practice

Abstract

Ocular surface complications are common yet underrecognized in critically ill patients undergoing mechanical ventilation. This review synthesizes current scientific evidence on the epidemiology, pathophysiology, risk factors, clinical features, diagnostic approaches, and management strategies for ocular surface protection in this population. Mechanism-based explanations and recent guideline recommendations are provided to inform best practices and improve patient outcomes. Special attention is given to emerging therapies and clinical pearls relevant for intensive care providers, ophthalmologists, and multidisciplinary healthcare teams.

Introduction

Mechanical ventilation is a cornerstone of care for critically ill patients, but the focus on life-sustaining respiratory management can overshadow secondary complications such as ocular surface disorders. The loss of normal protective mechanisms, including eyelid closure and blink reflex, places ventilated patients at heightened risk for exposure keratopathy and infectious sequelae. This article provides a comprehensive and clinically focused overview of ocular surface protection in mechanically ventilated patients, emphasizing the importance of early recognition and multidisciplinary intervention for optimal care.

Epidemiology / Disease Burden

Ocular surface complications occur in 20–60% of mechanically ventilated patients, depending on ICU protocols and patient risk profiles. Exposure keratopathy is the most prevalent manifestation, with reported incidence ranging from 37% to 60% in prospective studies. Nosocomial infections, such as microbial keratitis and conjunctivitis, although less common, can result in permanent visual impairment. Underdiagnosis is a significant issue, as ocular assessments may not be routinely incorporated into ICU care bundles. The disease burden extends beyond acute morbidity, with potential for long-term sequelae such as corneal scarring, vision loss, and increased healthcare utilization.

Pathophysiology

Mechanical ventilation leads to ocular surface vulnerability through multiple mechanisms. Sedation, neuromuscular blockade, and reduced consciousness impair eyelid closure (lagophthalmos) and blink reflex, disrupting the tear film and exposing the cornea to desiccation. Additionally, positive pressure ventilation may exacerbate periocular edema and disrupt lymphatic drainage. The loss of Bell's phenomenon and decreased basal tear secretion further compromise corneal defense. These changes collectively increase susceptibility to epithelial breakdown, microbial colonization, and subsequent inflammation or infection.

Risk Factors

Risk factors for ocular surface complications in ventilated patients include prolonged sedation, deep neuromuscular blockade, high positive end-expiratory pressure (PEEP), prone positioning, facial edema, reduced tear production, and pre-existing ocular conditions. Patient-related factors such as diabetes, autoimmune diseases, and advanced age may further increase vulnerability. Environmental and iatrogenic contributors include low ambient humidity, use of certain topical medications (e.g., vasoconstrictors), and suboptimal eye care practices within the ICU.

Clinical Features

Exposure keratopathy often presents with corneal dryness, epithelial defects, punctate erosions, and conjunctival injection. In the absence of prompt intervention, corneal ulceration, stromal melting, and superimposed infection may develop. Clinically, patients may exhibit incomplete eyelid closure, visible corneal opacities, or chemosis. Signs are frequently subtle, especially in sedated or non-communicative patients, emphasizing the need for regular ocular assessment by trained staff. Advanced presentations can include hypopyon, purulent discharge, and, rarely, endophthalmitis.

Diagnosis

Diagnosis is primarily clinical, based on bedside examination for lagophthalmos, conjunctival injection, and corneal changes. Fluorescein staining under cobalt blue light is the gold standard for detecting epithelial defects. Slit lamp biomicroscopy, when available, provides detailed assessment. Microbiological cultures are indicated for suspected infectious keratitis. Standardized ocular checklists and regular nursing documentation have been shown to improve detection rates and facilitate early intervention.

Treatment & Management

Preventive strategies are the cornerstone of ocular surface protection during mechanical ventilation. Regular application of lubricating eye drops or ointments, eyelid taping or patching, and maintenance of optimal eyelid closure are first-line measures. In high-risk patients, moisture chambers or polyethylene film dressings can further reduce evaporation. For established keratopathy, intensified lubrication, antibiotic prophylaxis, and ophthalmology referral are indicated. Infectious complications require targeted antimicrobial therapy guided by culture results. Multidisciplinary education and inclusion of ocular care protocols in ICU checklists are essential for consistent implementation.

Recent Advances / Emerging Therapies

Recent innovations include novel moisture-retaining devices, such as hydrogel-based shields and self-adhering transparent patches, which provide more stable ocular surface protection compared to traditional methods. Studies have explored the utility of preservative-free lubricants and autologous serum eye drops for refractory cases. Teleophthalmology and digital imaging enable remote specialist input, particularly valuable in resource-limited settings. The role of anti-inflammatory agents and growth factors is under investigation, with early data suggesting potential benefits in promoting corneal healing.

Guideline Recommendations

Consensus guidelines from critical care and ophthalmology societies recommend systematic ocular assessment at least once per nursing shift for all mechanically ventilated patients. Prophylactic lubrication and eyelid closure interventions should be initiated for patients with impaired consciousness or incomplete blink. Education of ICU teams, standardized protocols, and early ophthalmology consultation for high-risk or refractory cases are strongly advised. Key recommendations include the avoidance of adhesive tapes that may injure the skin, preference for preservative-free products, and prompt investigation of any new ocular findings.

Conclusion

Ocular surface protection is a vital yet often overlooked aspect of care in mechanically ventilated patients. Awareness of the epidemiology, pathophysiology, and risk factors enables early identification and intervention, mitigating the risk of sight-threatening complications. Integration of evidence-based protocols, ongoing staff education, and adoption of emerging therapies can significantly improve clinical outcomes. Multidisciplinary collaboration remains paramount to ensure comprehensive ocular care in the intensive care setting.